Baseline characteristics of the study population
| Characteristic . | AMI group (n = 20) . | CSA group (n = 20) . |
|---|---|---|
| Mean age, y (range) | 61.5 (42-80) | 63.5 (38-83) |
| Sex: M/F | 17/3 | 15/5 |
| Hypercholesterolemia | 11 | 15 |
| Arterial hypertension | 12 | 14 |
| Smoker | 7 | 5 |
| Diabetes mellitus | 3 | 5 |
| One-vessel disease | 5 | 4 |
| Two-vessel disease | 8 | 5 |
| Three-vessel disease | 7 | 11 |
| Mean ± SD time from onset of pain to blood sampling (h) | 14 ± 6 | — |
| Mean ± SD peak creatine kinase level (U/L) | 1249 ± 1135 | — |
| Target vessel | ||
| LAD | 10 | — |
| LCx | 5 | — |
| RCA | 5 | — |
| Venous bypass graft | 0 | — |
| Characteristic . | AMI group (n = 20) . | CSA group (n = 20) . |
|---|---|---|
| Mean age, y (range) | 61.5 (42-80) | 63.5 (38-83) |
| Sex: M/F | 17/3 | 15/5 |
| Hypercholesterolemia | 11 | 15 |
| Arterial hypertension | 12 | 14 |
| Smoker | 7 | 5 |
| Diabetes mellitus | 3 | 5 |
| One-vessel disease | 5 | 4 |
| Two-vessel disease | 8 | 5 |
| Three-vessel disease | 7 | 11 |
| Mean ± SD time from onset of pain to blood sampling (h) | 14 ± 6 | — |
| Mean ± SD peak creatine kinase level (U/L) | 1249 ± 1135 | — |
| Target vessel | ||
| LAD | 10 | — |
| LCx | 5 | — |
| RCA | 5 | — |
| Venous bypass graft | 0 | — |
Values are numbers of patients unless otherwise indicated.
LAD indicates left anterior descending coronary artery; LCx, left circumflex coronary artery; and RCA, right coronary artery.